Last updated: April 8, 2024
Sponsor: Beni-Suef University
Overall Status: Active - Recruiting
Phase
N/A
Condition
Cardiac Surgery
Treatment
lidocaine infusion
pecto intercostal fascial block using bupivacaine 0.25%
Clinical Study ID
NCT05885230
FMBSUREC/09042023/Mikhael
Ages 18-75 All Genders Accepts Healthy Volunteers
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- age between 18 and 75 years.
- patient scheduled to undergo elective on-pump cardiac surgery with sternotomy.
- American Society of Anesthesiologists classification of physical status < IV.
Exclusion
Exclusion Criteria:
- emergency surgery.
- off-pump surgery.
- redo surgery.
- ejection fraction less than 35%.
- refusal of the patient.
- known hypersensitivity to LA.
- chronic opioid use or chronic pain patient.
- psychiatric problems or communication difficulties.
- liver insufficiency (defined as a serum bilirubin ≥ 34 μmol/l, albumin ≤ 35 g/dl, INR ≥ 1.7).
- renal insufficiency (defined as a glomerular filtration rate < 44 ml/min).
- obstructive sleep apnea syndrom.
- coexisting hematologic disorders.
- pregnancy or breastfeeding.
Study Design
Total Participants: 138
Treatment Group(s): 2
Primary Treatment: lidocaine infusion
Phase:
Study Start date:
May 01, 2023
Estimated Completion Date:
May 31, 2024
Study Description
Connect with a study center
Benisuef University Hospital
Banī Suwayf, e\EYGPT
EgyptActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.